Login / Signup

Association of anticoagulant use with clinical outcomes from crizotinib in ALK- and ROS1-rearranged advanced non-small cell lung cancers: A retrospective analysis of PROFILE 1001.

Terry L NgDavid C C TsuiSherry WangTiziana UsariTejas PatilKeith WilnerDavid R Camidge
Published in: Cancer medicine (2022)
gov: NCT00585195.
Keyphrases
  • advanced non small cell lung cancer
  • single cell
  • atrial fibrillation
  • venous thromboembolism
  • cell death
  • cell therapy
  • dna damage
  • reactive oxygen species
  • stem cells
  • epidermal growth factor receptor